Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis
JTCVS Open · 2024-04 · 18 · 64-79
DOI: 10.1016/j.xjon.2024.02.009 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JTCVS Open, 2024-04. Verfasst von Michele Dell'Aquila und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Subclinical hypothyroidism (SCH) is associated with major adverse cardiovascular events. Despite the recognized negative impact of SCH on cardiovascular health, research on cardiac postoperative outcomes with SCH has yielded conflicting results, and patients are not currently treated for SCH before cardiac surgery procedures.
Methods
We performed a study-level meta-analysis on the impact of SCH on patients undergoing nonurgent cardiac surgery, including coronary artery bypass grafting and valve and aortic surgery. The primary outcome was operative mortality. Secondary outcomes were hospital length of stay (LOS), intensive care unit (ICU) stay, postoperative atrial fibrillation (POAF), intra-aortic balloon pump (IABP) use, renal complications, and long-term all-cause mortality.
Results
Seven observational studies, with a total of 3445 patients, including 851 [24.7%] diagnosed with SCH and 2594 [75.3%] euthyroid patients) were identified. Compared to euthyroid patients, the patients with SCH had higher rates of operative mortality (odds ratio [OR], 2.57; 95% confidence interval [CI], 1.09-6.04; P = .03), prolonged hospital LOS (standardized mean difference, 0.32; 95% CI, 0.02-0.62; P = .04), a higher rate of renal complications (OR, 2.53; 95% CI, 1.74-3.69; P < .0001), but no significant differences in ICU stay, POAF, or IABP use. At mean follow-up of 49.3 months, the presence of SCH was associated with a higher rate of all-cause mortality (incidence rate ratio, 1.82; 95% CI, 1.18-2.83; P = .02).
Conclusions
Patients with SCH have higher operative mortality, prolonged hospital LOS, and increased renal complications after cardiac surgery. Achieving and maintaining a euthyroid state prior to and after cardiac surgery procedures might improve outcomes in these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
- Department of Cardiothoracic Surgery, Friedrich Schiller University, Jena, Germany.
- Division of Cardiac Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
- Department of General Surgery, Maimonides Medical Center, Brooklyn, NY.
- Samuel J. Wood Library & CV Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY.
Zitieren
APA
Dell'Aquila, M., Rossi, C. S., Caldonazo, T., Cancelli, G., Harik, L., Soletti, G. J., An, K. R., Leith, J., Kirov, H., Ibrahim, M., Demetres, M., Dimagli, A., Rahouma, M., & Gaudino, M. (2024). Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis. JTCVS Open, 18, 64-79. https://doi.org/10.1016/j.xjon.2024.02.009
Vancouver
Dell'Aquila M, Rossi CS, Caldonazo T, Cancelli G, Harik L, Soletti GJ, et al. Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis. JTCVS Open. 2024;18:64-79. doi:10.1016/j.xjon.2024.02.009
BibTeX
@article{DellAquila2024,
author = {Dell'Aquila, Michele and Rossi, Camilla S and Caldonazo, Tulio and Cancelli, Gianmarco and Harik, Lamia and Soletti, Giovanni J and An, Kevin R and Leith, Jordan and Kirov, Hristo and Ibrahim, Mudathir and Demetres, Michelle and Dimagli, Arnaldo and Rahouma, Mohamed and Gaudino, Mario},
title = {Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis},
journal = {JTCVS Open},
year = {2024},
volume = {18},
pages = {64--79},
doi = {10.1016/j.xjon.2024.02.009}
}
EUVIMED